Yuyue Ren
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Innate immunity in tumors: roles and therapeutic targets.
Journal: Frontiers in immunology
Published: August 20, 2025
First report of B-lymphoblastic leukemia harboring LRRFIP1::FGFR1 fusion: expanding the clinical spectrum of myeloid/lymphoid neoplasms with tyrosine kinase gene fusions.
Journal: Annals of hematology
Published: May 13, 2025
Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value.
Journal: Cancer gene therapy
Published: March 25, 2025
Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients.
Journal: BMC cancer
Published: December 26, 2022
Coexistence of Pure Red Cell Aplasia and Autoimmune Haemolytic Anaemia Associated with Thymoma.
Journal: Acta haematologica
Published: April 10, 2019
Orai1 and Stim1 Mediate the Majority of Store-Operated Calcium Entry in Multiple Myeloma and Have Strong Implications for Adverse Prognosis.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: April 25, 2017
Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 09, 2016
Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
Journal: Cell cycle (Georgetown, Tex.)
Published: April 29, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026